LIK LIMES Schlosskliniken AG
LIMES Schlosskliniken AG operates private clinics for psychiatry, psychotherapy, and psychosomatics services in Germany, Switzerland, Italy, and Liechtenstein. The company focuses on the treatment of stress-related illnesses; and mental and psychological disorders, such as depression, acute burnout, affective disorders, trauma/PTSD, anxiety disorders, attention deficit hyperactivity disorder, personality disorder, chronic pain, psychoses, obsessive compulsive disorder, sleep disorder, somatoform disorder, and sports psychiatry. The company was formerly known as GMF Capital AG and changed its name to LIMES Schlosskliniken AG in December 2005. LIMES Schlosskliniken AG was founded in 2005 and is headquartered in Cologne, Germany. The company operates as a subsidiary of GMF Capital GmbH.…
Industry Peers
Medical Care FacilitiesKey Statistics
About LIMES Schlosskliniken (ETR: LIK)
›
LIMES Schlosskliniken (ETR: LIK) is listed on Xetra (Frankfurt), where its shares trade in EUR. It belongs to the Medical Care Facilities industry, part of the Healthcare sector, and reports about 314 employees.
The shares were at 590.00 EUR on 19 November 2026, up 70.5% over 52 weeks. Its 52-week range is 316.00 EUR to 600.00 EUR: the price is 1.7% below the high and 86.7% above the low.
At a market capitalisation of 175.79M EUR, it trades at 31.7 times trailing earnings and 11.4 times forward earnings. The median trailing P/E of its 18 largest Medical Care Facilities peers is 23.7, a premium of 34% for LIK. It pays a dividend yielding 1.72% (it pays out 55% of its earnings), against a median of 0.75% among the dividend payers in that peer group.
LIMES Schlosskliniken reports return on equity of 22.5%, an operating margin of 16.6% and revenue up 29.2% year over year.
Its debt exceeds its cash by 515.47K EUR, a debt-to-equity ratio of 0.42. Its Piotroski F-score is 6 out of 9, an average reading of its financial health. 2 analysts cover the stock; their mean price target of 697.50 EUR is 18.2% above the current price.